Methylfolate as Monotherapy in Depression. A Pilot Randomised Controlled Trial
Journal Title: Journal of Neurology and Psychology - Year 2015, Vol 3, Issue 1
Abstract
Background: The commonest neuropsychiatric complication of severe folate deficiency is depression. Placebo controlled trials of folates as adjunctive therapy in major depression have confirmed that they enhance the response to standard antidepressant medication, even in the absence of folate deficiency. We have undertaken a pilot randomised controlled trial of 5-methyltetrahydrofolate (5- MTHF) monotherapy against Amitriptyline in out-patients with mild to moderate depression. Methods: 31 patients, aged 20 – 69 years with DSM-111-R criteria for a depressive episode of mild to moderate severity and a Montgomery Asberg Depression Score (MADS) of at least 14 were randomly allocated to 5-MTHF 50 mgs (25 mgs biologically active) or Amitriptyline 150 mgs for 6 weeks. Clinical response was defined as a fall in MADS of 25% or more. Non-responders to initial therapy were crossed over to the alternative active therapy for a further six weeks. Haemoglobin, mean cell volume, serum and red cell folate and serum vitamin B12 were measured at entry to the study, after six weeks of initial and crossover treatment and at six months. Results: Of 19 patients randomised (n = 16) or crossed over (n = 3) to treatment with 5-MTHF for six weeks, eight (42%) responded. Of 20 patients randomised (n = 15) or crossed over (n = 5) to Amitriptyline, seven (35%) responded. Only 3 patients (10%) had low or borderline red cell folate values at randomisation. Response to 5-MTHF was associated with a significantly greater rise in red cell folate. Conclusions: Placebo controlled trials of 5-MTHF as monotherapy in depression would be justifiable. Our observations together with studies of S-adenosylmethionine (SAM) and nitrous oxide (N2O) are consistent with the hypothesis that 5-MTHF has intrinsic mood elevating properties in some patients.
Authors and Affiliations
Edward H Reynolds
Keywords
Related Articles
- EP ID EP197342
- DOI 10.13188/2332-3469.1000019
- Views 164
- Downloads 0
Anti-Genetic Exceptionalism in Complex Disorders: Making a Case for Disclosure of Polymorphic Genetic Results in Clinical Research Studies
It is increasingly common for clinical research studies to include a genetic component. In complex genetic disorders, disease is associated with variation in many genes, each of which contributes only a small, discrete e...
Interpersonal Psychotherapy Efficacy in Different Clinical Settings
Interpersonal therapy is an effective brief and limited therapy originally developed for major depression disorder but nowadays also highly effective in other psychiatric disorders [1,2]. This therapy uses the biopsychos...
Treatment Gap in Childhood Epilepsy (TGCE): Pakistan Regional Study in Under-Resourced Community
Background: The epidemiological data on childhood epilepsy, essential to plan services in resource constrained developing nations, is scarce. Identifying the determinants of treatment gaps in childhood epilepsy is essent...
Weight Reduction Aids Antiepileptic Therapy to Restore Ovarian Functions of Epileptic Polycystic Ovary Women
Objectives: To evaluate the hormonal profile of epileptic women with polycystic ovary (PCOS) and to determine the impact of weight reduction regimen on their ovulatory function in comparison to nonepileptic PCOS women an...
Assessment of Autonomic Function in Patients with Schizophrenia Using Spectral Analysis and Approximate Entropy Method
Objective: Autonomic nervous system involvement in patients with Schizophrenia has rarely been studied and has shown conflicting results. Our main purpose was to demonstrate that the Schizophrenia patients have malfuncti...